PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012
CPAP induces structural changes in the inspiratory muscles of patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 222s Year: 2002
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003
Does personality change in obstructive sleep apnea (OSA) patients using CPAP? Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006
Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004
Residual sleepiness in obstructive sleep apnea (OSA) patients on CPAP: Not only a symptom but rather a true syndrome? Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012
Effect of obstructive sleep apnea syndrome (OSAS) on cognitive performances Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
CPAP therapy improves endothelial dysfunction in obstructive sleep apnea hypopnea syndrome (OSAHS) Source: Eur Respir J 2004; 24: Suppl. 48, 565s Year: 2004
Disturbances of respiratory muscles in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 418s Year: 2006
Neurophysiological properties of the tongue in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 495s Year: 2002
Influence of electrostimulation of pharyngeal and laryngeal muscles in complex with traditional treatment of COPD on functional signs of obstructive sleep apnea syndrome in patients with combined pathology – obstructive sleep apnea syndrome + COPD Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
CPAP variability in long term follow-up of OSAS (obstructive sleep apnea syndrome) patients Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006
The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006
Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002
Fibrinogen level in patients with severe obstructive sleep apnoea syndrome (OSAS). Effect of n-CPAP therapy Source: Eur Respir J 2001; 18: Suppl. 33, 216s Year: 2001
Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009
Does PAP treatment in obstructive sleep apnea (OSA) patients change functional MRI activation? Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008
A comparison of respiratory functions, peripheral muscle strength and postural impairments between patients with different severity of obstructive sleep apnea syndrome (OSAS) Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy Year: 2020
Comparisson of corrective effects of APAP and CPAP on disordered autonomic nervous system function in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007
Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009